Assessment of prognosis in chronic coronary artery disease

Heart

Volumn 90, Issue SUPPL. 5, 2004, Pages

  Bateman, T M ^a   Prvulovich, E ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201; TRACER; VASODILATOR AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC DISEASE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; THORAX PAIN;

CHEST PAIN; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; COST-BENEFIT ANALYSIS; DIABETIC ANGIOPATHIES; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; RADIONUCLIDE ANGIOGRAPHY; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 3242878497     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.018770     Document Type: Article

References (39)

1. Klocke F, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging. J Am Coll Cardiol 2003;42:1318-33.
2. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
3. Gill JB, Ruddy TD, Newell JB, et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987;317:1486-9.
4. Weiss AT, Berman DS, Lew AS, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.
5. Gioia G, Milan E, Giubbini R, et al. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1996;3:150-6.
6. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
7. Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831-47.
8. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-66.
9. Ladenheim ML, Kotler TS, Pollock BH, et al. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol 1987;59:270-7.
10. Iskandrian AS, Chae SC, Heo J, et al. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-70.
11. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793-801.
12. Chatziioannou SN, Moore WH, Ford PV, et al. Prognostic value of myocardial perfusion imaging in patients with high exercise tolerance. Circulation 1999;99:867-72.
13. Sharir T, Germano G, Kavanagh K, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
14. Johnson LL, Verdesca SA, Aude WY, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997;30:1641-8.
15. Bateman TM, O'Keefe JH Jr, Dong VM, et al. Coronary angiography rates following stress SPECT scintigraphy. J Nucl Cardiol 1995;2:217-23.
16. Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999;33:661-9.
17. Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996;28:34-44.
18. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100:2140-5.
19. Wagdy HM, Hodge D, Christian TF, et al. Prognostic value of vasodilator myocardial perfusion imaging in patients with left bundle-branch block. Circulation 1998;97:1563-70.
20. O'Keefe JH, Bateman TM, Silvestri R, et al. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart J 1992;124:614-21.
21. Navare SM, Mather JF, Fowler MS, et al. Are there differences in risk stratification of patients with known or suspected coronary disease between pharmacologic and exercise stress myocardial perfusion imaging? A meta-analysis [abstract]. J Nucl Cardiol 2002;4:S22.
22. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
23. Yusuf S, Sucker D, Peruse P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomized trials by the coronary artery bypass graft surgery realists collaboration. Lancet 1994;344:563-70.
24. Dahan M, Viron B, Faraggi M, et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in haemodialysis patients. Kidney Int 1998;54:255-62.
25. Lauer MS, Lytle B, Pashkow F, et al. Prediction of death and myocardial infarction by screening with exercise thallium testing after coronary artery bypass grafting. Lancet 1998;351:615-22.
26. Nallamothu N, Johnson JH, Bagheri B, et al. Utility of stress single photon emission computed tomography (SPECT) perfusion imaging in predicting outcome after coronary artery bypass grafting. Am J Cardiol 1997;80:1515-21.
27. Zellweger MJ, Lewin HC, Lai S, et al. When to stress patients after coronary artery bypass surgery. J Am Coll Cardiol 2001;37:144-52.
28. Hecht HS, Shaw RE, Chin HL, et al. Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991;17:670-7.
29. Brown KA, Heller GV, Landin RS, et al. Early dipyridamole Tc-99m sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and post-discharge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060-6.
30. Mahmarian JJ, Mahmarian AC, Marks GF, et al. Role of adenosine thallium-201 tomography for defining long-term risk in patients after myocardial infarction. J Am Coll Cardiol 1995;25:1333-40.
31. Bax JJ, Wijns W, Cornel JH, et al. Accuracy of currently available techniques for prediction of functional recovery after revascularisation in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
32. DiCarli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;74:527-33.
33. L'Italien GJ, Paul S, Hendel RC, et al. Development and validation of a Bayesian model for postoperative cardiac risk assessment in a cohort of 1081 vascular surgical candidates. J Am Coll Cardiol 1996;27:779-86.
34. ACC/AHA Practice Guidelines. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Circulation 1996;93:1278-317.
35. Beller GA, Zaret B. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2001;10:1465-78.
36. Prvulovich E, Metcalfe MJ. Nuclear cardiology in the UK: activity and practice 1997. Eur J Nucl Med 2002;29:553-8.
37. Maier W, Windecker S, Lablanche JM, Muhlberger V, Wijns W, Meier B on behalf of the working Group Coronary Circulation of the European Society of Cardiology. The European Registry of cardiac catheter interventions 1996. Eur Heart J 2001;22:567-73.
38. British Cardiac Society. Council statement on the demand and need for cardiac services and the development of a waiting list strategy for cardiac disease. London: British Cardiac Society, July 1994.
39. Prvulovich E, Jarritt PH, Vivian GC, et al. Quality assurance in myocardial perfusion tomography: a collaborative BNCS/BNMS audit programme. Nucl Med Comm 1998;19:831-8.